Mortality risk factors among non-ICU patients with nosocomial vascular catheter-related bloodstream infections: a prospective cohort study

doi:10.1016/j.jhin.2017.11.002

Journal of Hospital Infection

Volume 99, Issue 1, May 2018, Pages 48-54

https://doi.org/10.1016/j.jhin.2017.11.002 Get rights and content

Summary

Background

Vascular catheter-related bloodstream infections (CRBSIs) are highly preventable hospital-acquired infections and a major threat to patient safety. While there is significant information regarding CRBSI outcome among intensive care unit (ICU) patients, data regarding non-ICU patients are scarce.

Aim

To determine the risk factors associated with 30-day mortality among non-ICU patients with nosocomial CRBSIs.

Methods

Prospective cohort study of non-ICU patients with nosocomial CRBSIs in a tertiary care centre between January 2004 and December 2014. The primary outcome was 30-day mortality, defined as death from any cause within 30 days of CRBSI. Follow-up was performed 30 days after CRBSI onset. Time until death was the dependent variable in Cox regression analysis.

Findings

In total, 546 cases of CRBSI were identified. The mean age of patients was 64.5 years [interquartile range (IQR) 55–75 years], 66% were male, and the mean Charlson score was 3.59 (IQR 2–5). Of the 546 cases, 58.4% resulted from central venous catheters and 41.6% from peripheral venous catheters. The causative agents were Gram-positive cocci (70.1% of cases), Gram-negative bacilli (31.1%) and Candida spp. (1%). Mortality within 30 days was 13.9%, with no significant changes over the study period. Independent risk factors for 30-day mortality were Charlson score ≥4 [hazard ratio (HR) 1.80, 95% confidence interval (CI) 1.19–2.73], Staphylococcus aureus infection (HR 2.67, 95% CI 1.61–4.43) and Candida spp. infection (HR 6.1, 95% CI 2.08–18.04). Age; area of admission; type, use and site of vascular catheter; and administration of appropriate empirical antibiotic treatment were not independent risk factors for 30-day mortality.

Conclusion

Nosocomial CRBSIs outside ICUs are associated with high risk of mortality, particularly among patients with a higher Charlson score and bloodstream infections caused by Staphylococcus aureus and Candida spp.

Introduction

Vascular catheters are the most commonly used medical devices in hospitals. According to a large European prevalence study, a vascular catheter was present in almost 55% of hospitalized patients [1]. Almost all of the patients required one or more vascular catheters during hospitalization for therapeutic support, haemodynamic monitoring or diagnostic procedures. In non-intensive care units (non-ICUs), vascular catheter utilization, measured as the ratio of device-days to patient-days, is lower than in ICUs, but the total burden of catheters in use is higher in the non-ICU setting [2].

Adverse events related to vascular catheterization are common. Catheter-related bloodstream infections (CRBSIs) are among the most serious complications, causing high morbidity, high mortality and a rise in hospital costs [3]. The incidence of CRBSIs varies according to vascular catheter type, characteristics and insertion site [4]. Consequently, CRBSI rates are higher for central venous catheters (CVCs) than for peripheral venous catheters (PVCs), although the high number of patients exposed to PVCs means that the absolute number of PVC BSIs could be substantial [5], [6], [7].

CRBSIs are the most preventable cause of healthcare-related infections [8]. Over the last decade, the implementation of interventions to prevent CRBSIs has led to a significant and sustained reduction in the incidence of infection, particularly in ICUs, but also in non-ICU settings [9], [10], [11]. However, most studies have focused on the epidemiology and outcomes of CRBSIs in the ICU setting, and scarce information is available regarding non-ICU settings. Identifying risk factors associated with CRBSI mortality is relevant to improving patient outcomes. The aim of this study was to determine the risk factors associated with 30-day mortality among patients with nosocomial CRBSIs on non-ICU wards.

Section snippets

Study design, setting and population

A prospective cohort study was conducted at Bellvitge University Hospital, a 700-bed tertiary care teaching hospital for adults in Barcelona, Spain. Each year, an average of 28,000 patients are admitted (approximately 340,000 patient-days). The primary outcome was 30-day crude mortality among non-ICU patients with nosocomial CRBSIs. The inclusion criteria were: consecutive episodes of nosocomial CRBSIs diagnosed during admission to medical and surgical wards between January 2004 and December

Results

During the study period, 546 episodes of CRBSI were diagnosed in 537 non-ICU patients. The CRBSI rate was 0.23/1000 patient-days. Thirty-day mortality was 13.9% (76 of 546 episodes) and did not vary significantly during the study period (Figure 1). Mortality varied according to co-morbidities, type of ward, type of catheter, insertion site and aetiology (Table I). Univariate and multi-variate analyses of risk factors associated with 30-day mortality are presented in Table II. Significant

Discussion

The main finding of this study is that CRBSIs in non-ICU patients are associated with a significant risk of mortality, which is affected by patient co-morbidities and aetiology. Importantly, the mortality rate among patients with CRBSIs did not vary significantly over the study period.

Vascular catheters are widely used outside ICUs and some studies have shown that rates of CVC BSIs in non-ICU patients could be similar to those observed in ICUs. However, few experiences regarding the

Acknowledgements

The authors wish to thank the Department of Microbiology of Bellvitge University Hospital (MA Dominguez) for study support.

References (26)

V. Stevens et al.
Inpatient costs, mortality and 30-day re-admission in patients with central-line-associated bloodstream infections
Clin Microbiol Infect
(2014)
D.G. Maki et al.
The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies
Mayo Clin Proc
(2006)
M. Pujol et al.
Clinical epidemiology and outcomes of peripheral venous catheter-related bloodstream infections at a university-affiliated hospital
J Hosp Infect
(2007)
W. Zingg et al.
Hospital-wide surveillance of catheter-related bloodstream infection: from the expected to the unexpected
J Hosp Infect
(2009)
B. Almirante et al.
VINCat Program. Laboratory-based surveillance of hospital-acquired catheter-related bloodstream infections in Catalonia. Results of the VINCat Program (2007–2010)
Enferm Infecc Microbiol Clin
(2012)
S. Harbarth et al.
The preventable proportion of nosocomial infections: an overview of published reports
J Hosp Infect
(2003)
N. Freixas et al.
Impact of a multimodal intervention to reduce bloodstream infections related to vascular catheters in non-ICU wards: a multicentre study
Clin Microbiol Infect
(2013)
M.E. Charlson et al.
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
J Chron Dis
(1987)
W. Zingg et al.
Peripheral venous catheters: an under-evaluated problem
Int J Antimicrob Agents
(2009)
J.J. Gagne et al.
A combined comorbidity score predicted mortality in elderly patients better than existing scores
J Clin Epidemiol
(2011)

P. Zarb et al.

National contact points for the ECDC pilot point prevalence survey, hospital contact points for the ECDC pilot point prevalence survey. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use

Euro Surveill

(2012)

A.J. Kallen et al.

Preventing catheter-related bloodstream infections outside the intensive care unit: expanding prevention to new settings

Clin Infect Dis

(2010)

P. Pronovost et al.

An intervention to decrease catheter-related bloodstream infections in the ICU

N Engl J Med

(2006)

Cited by (37)

Peripheral intravenous catheter infection and failure: A systematic review and meta-analysis
2024, International Journal of Nursing Studies
Peripheral intravenous catheters are the most frequently used invasive device in nursing practice, yet are commonly associated with complications. We performed a systematic review to determine the prevalence of peripheral intravenous catheter infection and all-cause failure.
The Cochrane Library, PubMed, CINAHL, and EMBASE were searched for observational studies and randomised controlled trials that reported peripheral intravenous catheter related infections or failure. The review was limited to English language and articles published from the year 2000. Pooled estimates were calculated with random-effects models. Meta-analysis of observation studies in epidemiology guidelines and the Cochrane process for randomised controlled trials were used to guide the review. Prospero registration number: CRD42022349956.
Our search retrieved 34,725 studies. Of these, 41 observational studies and 28 randomised controlled trials (478,586 peripheral intravenous catheters) met inclusion criteria. The pooled proportion of catheter-associated bloodstream infections was 0.028 % (95 % confidence interval (CI): 0.009–0.081; 38 studies), or 4.40 catheter-associated bloodstream infections per 100,000 catheter-days (20 studies, 95 % CI: 3.47–5.58). Local infection was reported in 0.150 % of peripheral intravenous catheters (95 % CI: 0.047–0.479, 30 studies) with an incidence rate of 65.1 per 100,000 catheter-days (16 studies; 95 % CI: 49.2–86.2). All cause peripheral intravenous catheter failure before treatment completion occurred in 36.4 % of catheters (95 % CI: 31.7–41.3, 53 studies) with an overall incidence rate of 4.42 per 100 catheter days (78,891 catheter days; 19 studies; 95 % CI: 4.27–4.57).
Peripheral intravenous catheter failure is a significant worldwide problem, affecting one in three catheters. Per peripheral intravenous catheter, infection occurrence was low, however, with over two billion catheters used globally each year, the absolute number of infections and associated burden remains high. Substantial and systemwide efforts are needed to address peripheral intravenous catheter infection and failure and the sequelae of treatment disruption, increased health costs and poor patient outcomes.
Interventions to reduce peripheral intravenous catheter failure: An international e-Delphi consensus on relevance and feasibility of implementation
2023, Journal of Infection and Public Health
Around 1 billion peripheral intravenous catheters (PIVC) fail annually worldwide before prescribed intravenous therapy is completed, resulting in avoidable complications, dissatisfaction, and avoidable costs surging to ∼€4bn. We aimed to provide an international consensus on relevance and feasibility of clinical practice guideline recommendations to reduce PIVC failure.
e-Delphi study with three rounds through an online questionnaire from March-September 2020 recruiting a multispecialty panel formed by clinicians, managers, academic researchers, and experts in implementation from seven developed and three developing countries, reflecting on experience in PIVC care and implementation of evidence. Further, we included a panel of chronic patients with previous experience in the insert, maintenance, and management of PIVC and intravenous therapy from Ireland and Spain as public and patient involvement (PPI) panel. All experts and patients scored each item on a 4-point Likert scale to assess the relevance and feasibility. We considered consensus descriptor in which the median was 4 with less than or equal to 1,5 interquartile intervals.
Over 90% participants (16 experts) completed the questionnaire on all rounds and 100% PPI (5 patients) completed round 1 due to high consensus they achieved. Our Delphi approach included 49 descriptors, which resulted in an agreed 30 across six domains emerged from the related to (i) general asepsis and cutaneous antisepsis (n = 4), (ii) catheter adequacy and insertion (n = 3), (iii) catheter and catheter site care (n = 6), (iv) catheter removal and replacement strategies (n = 4), (v) general principles for catheter management (n = 10), and (vi) organisational environment (n = 3).
We provide an international consensus of relevant recommendations for PIVC, deemed feasible to implement in clinical settings. In addition, this methodological approach included substantial representation from clinical experts, academic experts, patient and public expertise, mitigating uncertainty during the implementation process with high-value recommendations to prevent PIVC failure based contextual and individual features, and economic resources worldwide.
Crystal violet-based assay for the assessment of bacterial biofilm formation in medical tubing
2023, Journal of Microbiological Methods
Decreased mortality among patients with catheter-related bloodstream infections at Catalan hospitals (2010–2019)
2022, Journal of Hospital Infection
Citation Excerpt :
Similarly, we recently described a downward trend in the episodes of CRBSI acquired in the ICUs, and those associated with central venous catheters at hospitals participating in the VINCat programme [5]. Therefore, some of the risk factors for death identified in this study and others were specially affected by the implemented preventive programmes [10,11,15]. Recognition of risk factors for death is highly valuable since it identifies the most vulnerable populations after an episode of CRBSI, and who are therefore potential targets for specific preventive actions.
The incidence of catheter-related bloodstream infections (CRBSIs) has fallen over the last decade, especially in intensive care units (ICUs).
To assess the existence of concomitant trends in outcomes and to analyse the current risk factors for mortality.
A multicentre retrospective cohort study was conducted at 24 Catalan hospitals participating in the Surveillance of healthcare-associated infections in Catalonia (VINCat). All hospital-acquired CRBSI episodes diagnosed from January 2010 to December 2019 were included. A common protocol including epidemiological, clinical, and microbiological data was prospectively completed. Mortality at 30 days after bacteraemia onset was analysed using the Cox regression model.
Over the study period, 4795 episodes of CRBSI were diagnosed. Among them, 75% were acquired in conventional wards and central venous catheters were the most frequently involved (61%). The 30-day mortality rate was 13.8%, presenting a significant downward trend over the study period: from 17.9% in 2010 to 10.6% in 2019 (hazard ratio (HR): 0.95; 95% confidence interval (CI): 0.92–0.98). The multivariate analysis identified age (HR: 1.03; 95% CI: 1.02–1.04), femoral catheter (1.78; 1.33–2.38), medical ward acquisition (2.07; 1.62–2.65), ICU acquisition (3.45; 2.7–4.41), S. aureus (1.59; 1.27–1.99) and Candida sp. (2.19; 1.64–2.94) as risk factors for mortality, whereas the mortality rate associated with episodes originating in peripheral catheters was significantly lower (0.69; 0.54–0.88).
Mortality associated with CRBSI has fallen in recent years but remains high. Intervention programmes should focus especially on ICUs and medical wards, where incidence and mortality rates are highest.
Clinical outcomes of suspected Catheter Related Blood Stream Infection at a tertiary care center in south India
2021, Indian Journal of Medical Microbiology
Citation Excerpt :
Higher incidence of Catheter related infections is seen with triple lumen catheters as compared to double and single lumen [5,6]. Staphylococcus aureus, Pseudomonas and Candida infections are associated with higher mortality [7,8]. Diagnosing CRBSI requires that the same organism should be isolated from the central line and peripheral line with a differential time to positivity of more than 2 h, this implies that the microbial load being higher in the central line resulted in earlier growth on the culture medium as compared to the blood taken from the peripheral line [9].
Catheter related blood stream infection (CRBSI) makes up a significant proportion of Hospital acquired infection and increases the morbidity and mortality of those affected.
Primary aim was to study the clinical outcomes of patients with suspected Catheter Related Blood Stream Infection (CRBSI).
Of the 150 participants suspected of having CRBSI, 100(67%) had CRBSI, 26(16%) patients were colonizers and 24(17%) patients had BSI from another source. Gram negative microbes were predominant. Clinical outcomes were studied with respect to mortality, complications and length of hospital stay. CRBSI participants had a significantly prolonged hospital stay. However no specific factors related to the host or the pathogen influenced this outcome.
CRBSI prolongs the hospital stay for patients who would have otherwise been discharged, hence increases the burden on hospital and human resources.
Complication risk factors related to central venous catheter in pediatric
2020, Annales Pharmaceutiques Francaises
A prospective epidemiological study was carried out in the pediatric intensive care unit (ICU), at the Mayotte Hospital Center (MHC). The purpose of the study was to identify and to evaluate complications risk factors related to central venous catheterization. Improving side effects prevention and patients care was the second goal.
Data collection took place over a period of 10 months. The central approaches followed in the study were femoral, jugular and subclavian. Since the database is composed of qualitative and quantitative variables, the Chi² test has been used to measure the association between two variables.
The study was carried out on 101 patients. Five infectious risk factors on the 10 variables evaluated have been significantly highlighted: the number of punctures, the number of repair of the dressing, the duration of the catheterization, the exposure time and the parenteral nutrition administration.
Evaluation of practices through audits, an appropriate training for the staff, the update and the standardization of procedures, development of standardized assembly of the devices should lower the incidence of complications related to the venous approach.
Une étude épidémiologique prospective a été réalisée dans l’unité de soins intensifs pédiatriques du centre hospitalier de Mayotte (CHM). Le but de l’étude était d’identifier et d’évaluer les facteurs de risque de complications liées au cathétérisme veineux central. La prévention des effets secondaires et l’amélioration des soins aux patients étaient les objectifs secondaires.
La collecte des données s’est déroulée sur une période de 10 mois. Les voies d’abords centrales suivies dans l’étude étaient fémorales, jugulaires et sous-claviculaires. Comme la base de données se compose de variables qualitatives et quantitatives, le test Chi² a été utilisé pour mesurer l’association entre deux variables.
La cohorte de l’étude comprenait 101 patients. Cinq facteurs de risque infectieux sur les 10 variables évaluées ont été mis en évidence de façon significative : le nombre de ponctions, le nombre de réfections du pansement, la durée du cathétérisme, le temps d’insertion du cathéter et l’administration de nutrition parentérale.
L’évaluation des pratiques par des audits, une formation appropriée du personnel, la mise à jour et la standardisation des procédures, la mise au point de montage standardisés des dispositifs médicaux pour la voie centrale devraient réduire l’incidence des complications liées à l’abord veineux central.

View all citing articles on Scopus

View full text

Mortality risk factors among non-ICU patients with nosocomial vascular catheter-related bloodstream infections: a prospective cohort study

Summary

Background

Aim

Methods

Findings

Conclusion

Introduction

Section snippets

Study design, setting and population

Results

Discussion

Acknowledgements

Clin Microbiol Infect

Mayo Clin Proc

J Hosp Infect

J Hosp Infect

Enferm Infecc Microbiol Clin

J Hosp Infect

Clin Microbiol Infect

J Chron Dis

Int J Antimicrob Agents

J Clin Epidemiol

National contact points for the ECDC pilot point prevalence survey, hospital contact points for the ECDC pilot point prevalence survey. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use

Euro Surveill

Preventing catheter-related bloodstream infections outside the intensive care unit: expanding prevention to new settings

Clin Infect Dis

An intervention to decrease catheter-related bloodstream infections in the ICU

N Engl J Med